Unclaimed Scholar Profile
Are you Grant Theron? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at National Health Laboratory ServiceASIDASID-8245-0115-6978 orcid.org/0000-0002-9216-2415
Grant Theron
National Health Laboratory Service
Faculty researcher at National Health Laboratory Service (ZA), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Tuberculosis Research and Epidemiology#Infectious Diseases and Tuberculosis#Mycobacterium research and diagnosis#Diagnosis and treatment of tuberculosis
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 9,631 | 4,623 |
| h-index | 55 | 41 |
| i10-index | 129 | 90 |
Annual Citation Growth
Verified Citations / Year0
2020462
2021+40%647
2022+29%832
2023+33%1.1k
2024-8%1.0k
2025-45%555
2026Scholarship Distribution & Proportions242 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:25% African Regional Citations (2,408) • 75% Global Research Impact (7,223)
242 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (242)
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Published in The Lancet Respiratory Medicine•2017
DOI: 10.1016/s2213-2600(17)30079-6 Verified Peer-Reviewed
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial
Published in The Lancet•2013
DOI: 10.1016/s0140-6736(13)62073-5 Verified Peer-Reviewed
Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting
Published in American Journal of Respiratory and Critical Care Medicine•2011
DOI: 10.1164/rccm.201101-0056oc Verified Peer-Reviewed
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
Published in The Lancet Respiratory Medicine•2014
DOI: 10.1016/s2213-2600(14)70031-1 Verified Peer-Reviewed
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial
Published in The Lancet•2016
DOI: 10.1016/s0140-6736(15)01092-2 Verified Peer-Reviewed
Showing 1 – 5 of 242 publications
1 / 49